Clinical Trial Update: Evaluation of Efficacy and Safety of Somatostatin Used as Inflow Modulator in Liver Transplantation. [Phase 1]

View source ↗

Summary

A completed Phase 1 clinical trial evaluating somatostatin as an inflow modulator to assess safety and efficacy in liver transplantation for patients with clini…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Portal Hypertension

Drugs mentioned

• Somatostatin (somatostatin)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Liver Transplant With Clinically Significant Portal Hypertension | Phase 1 | Status: COMPLETED